Member Exclusive

Seeking to cure the incurable - Canada and Japan setting the world pace for innovations in regenerative medicine

National Post article highlights the important role the Centre for Commercialization of Regenerative Medicine (CCRM) is taking to help Canadian cell therapy companies like RepliCel Life Sciences (TSX.V: RP) create pathways for commercialization in Canada and Japan.

Go to the profile of Lee Buckler
Mar 10, 2015

Please sign in or register for FREE

No comments yet.